Add to my selection

REVERPLEG (argipressine (acétate d'))

Medicine - Posted on Oct 10 2024

Active substance (DCI)

argipressine (arginine vasopressine)

history (2)

9/25/24

REVERPLEG (argipressin) - Catecholamine-refractory hypotension following septic shock

Summary of opinion Favourable opinion for the reimbursement of REVERPLEG (argipressin) in the treatment of catecholamine-ref...

CAV :
54321

icône flèche
2/27/19

REVERPLEG (argipressine (acétate d'))

Intérêt clinique insuffisant pour justifier son remboursement dans le traitement de l’hypotension réfractaire aux catécholam...

icône flèche

Technical information

ATC code

H01BA01

Manufacturer

AOP ORPHAN PHARMACEUTICALS FRANCE

Presentation

REVERPLEG 40 U.I./2 mL, solution à diluer pour perfusion
5 ampoules en verre de 2 ml (CIP : 34009 550 556 3 1)
10 ampoules en verre de 2 ml (CIP : 34009 550 556 4 8)

All our publications

Drug therapy

Peripheral vascular diseases

Vascular diseases - miscellaneous

My account

You do not have a saved search

No element in selection

REVERPLEG (argipressine (acétate d'))

REVERPLEG (argipressin) - Catecholamine-refractory hypotension following septic shock

REVERPLEG (argipressine (acétate d'))

Follow us :